Erythema multiforme as a reaction to imiquimod 5% cream.
We describe a patient with erythema multiformefollowing a local site reaction after the use of topicalimiquimod 5% cream and review the literature forprevious reports of this cutaneous adverse effect.
College of Medicine, The Ohio State University, Columbus.
Daniel A
DA
Yanes
Jessica A
JA
Kaffenberger
David R
DR
Carr
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000634:Aminoquinolines / Q000009:adverse effects*; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000077271:Imiquimod; D055623:Keratosis, Actinic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012536:Scalp Dermatoses / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D005938:Glucocorticoids; D000077271:Imiquimod